Immunizations for renal transplant candidates and recipients

Nature Clinical Practice Nephrology

Volumn 5, Issue 1, 2009, Pages 46-53

  Cohn, Jennifer ^a   Blumberg, Emily A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hepatitis; Influenza; Pneumococcal infection; Renal transplantation; Vaccination

Indexed keywords

3 O DESACYL 4' MONOPHOSPHORYL LIPID A; ALUMINUM SALT; AZATHIOPRINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; ERYTHROPOIETIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHORYL LIPID A; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; TYPHOID VACCINE; UNCLASSIFIED DRUG; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

BACTEREMIA; CHICKENPOX; CLINICAL TRIAL; DIPHTHERIA; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; EPIDEMIC ENCEPHALITIS; GRAFT RECIPIENT; HEPATITIS A; HEPATITIS B; HERPES ZOSTER; HUMAN; IMMUNIZATION; INFLUENZA; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MEASLES; MENINGITIS; MENINGOCOCCOSIS; MUMPS; PATIENT SAFETY; PERITONEAL DIALYSIS; PERTUSSIS; PNEUMOCOCCAL INFECTION; PNEUMONIA; POLIOMYELITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RABIES; REVIEW; RUBELLA; STREPTOCOCCUS PNEUMONIAE; TETANUS; TREATMENT CONTRAINDICATION; TREATMENT RESPONSE; TYPHOID FEVER; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX DYSPLASIA; VIRUS INFECTION; VIRUS PNEUMONIA;

HUMANS; IMMUNIZATION SCHEDULE; IMMUNOCOMPROMISED HOST; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY;

EID: 57849126847     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph1003     Document Type: Review

References (63)

1. Degos F and Degott C (1989) Hepatitis in renal transplant recipients. J Hepatol 9: 114-123
2. Kumar D et al. (2007) Invasive pneumococcal disease in solid organ transplant recipients -10-year prospective population surveillance. Am J Transplant 7: 1209-1214
3. Vilchez RA et al. (2002) Influenza virus infection in adult solid organ tranplant recipients. Am J Transplant 2: 287-291
4. Gabriel R et al. (1976) Virus infections and acute renal transplant rejection. Nephron 16: 282-286
5. Parnham AP et al. (1995) Primary varicella in adult renal transplant recipients: a report of three cases plus a review of the literature. Clin Transplant 9: 115-118
6. Halpert R et al. (1986) Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 68: 251-258
7. Boggild AK et al. Travel patterns and risk behavior in solid organ transplant recipients. J Travel Med 11: 37-43
8. Kotton CN et al. (2005) Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant 5: 8-14
9. Gilbertson D et al. (2003) Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int 63: 738-743
10. Gane E and Pilmore H (2002) Management of chronic viral hepatitis before and after renal transplantation. Transplantation 74: 427-437
11. Keane WR et al. (1978) Epidemic renal transplant rejection associated with influenza A Victoria. Proc Clin Dial Transplant Forum 8: 232-236
12. [No authors listed] (2004) Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 4 (Suppl 10): S160-S163
13. Avery RK and Ljungman P (2001) Prophylactic measures in the solid-organ recipient before transplantation. Clin Infect Dis 33 (Suppl 1): S15-S21
14. Miller E et al. (1999) Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis 33: 356-360
15. Bruguera M et al. (1990) Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in hemodialysis patients. Vaccine 8 (Suppl): S47-S49
16. Bel'eed K et al. (2002) Vaccination against hepatitis B infection in patients with end stage renal disease. Postgrad Med J 78: 538-540
17. Jadoul M and Goubau P (2002) Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients? Clin Nephrol 58: 301-304
18. Vagelli G et al. (1988) More about response to hepatitis B vaccine in hemodialysis patients. Nephron 49: 171
19. Linneman CC Jr et al. (1981) Response to pneumococcal vaccine in renal transplant and hemodialysis patients. Arch Intern Med 141: 1637-1640
20. Beyer WE et al. (1987) Trivalent influenza vaccine inpatients on haemodialysis: impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components. Vaccine 5: 43-48
21. Webb NJ et al. (2000) Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology Study Group. Arch Dis Child 82: 141-143
22. Advisory Committee on Immunization Practices (online June 2006) Guidelines for vaccinating kidney dialysis patients and patients with chronic kidney disease. [http://www.cdc.gov/vaccines/pubs/downloads/b_dialysis_guide. pdf] (accessed 1 May 2008)
23. Duchini A et al. (2003) Vaccinations for adult solidorgan transplant recipients: current recommendations and protocols. Clin Microbiol Rev 16: 357-364
24. [No authors listed] (2004) Viral hepatitis guidelines in hemodialysis and transplantation Am J Transplant 4 (Suppl 10): S72-S82
25. Kara IH et al. (2004) The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients. Vaccine 22: 3963-3967
26. Chow KM et al. (2006) Antibody response to hepatitis B vaccine in end-stage renal disease patients. Nephron Clin Pract 103: c89-c93
27. Fraser GM et al. (1994) Increasing serum creatinine and age reduce the response to hepatitis B vaccine in renal failure patients. J Hepatol 21: 450-454
28. Karahocagil M et al. (2006) Comparison of intramuscular and intradermal applications of hepatitis B vaccine in hemodialysis patients. Ren Fail 28: 561-565
29. Charest AF et al. (2000) A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 36: 976-982
30. Chau KF et al. (2004) Efficacy and side effects of intradermal hepatitis B vaccination in CAPD patients: a comparison with the intramuscular vaccination. Am J Kidney Dis 43: 910-917
31. Mat O et al. (2006) Primary high-dose intradermal hepatitis B vaccination in hemodialysis: cost-effectiveness evaluation at two years. Hemodial Int 10: 49-55
32. [No authors listed] (2001) Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 50: 1-43
33. Anandh U et al. (2000) Granulocyte-macrophage colony-stimulating factor as an adjuvant to hepatitis B vaccination in maintenance hemodialysis patients. Am J Nephrol 20: 53-56
34. Beran J (2008) Safety and Immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients. Expert Opin Biol Ther 8: 235-247
35. Stevens CE et al. (1984) Hepatitis B vaccine in patients receiving hemodialysis: immunogenicity and efficacy. N Engl J Med 311: 496-501
36. European Consensus Group on Hepatitis B Immunity (2000) Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 355: 561-565
37. Waite NM et al. (1995) Successful vaccination with intradermal hepatitis B vaccine in hemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine. J Am Soc Nephrol 5: 1930-1934
38. Choy BY et al. (2002) Immunogenicity of intradermal hepatitis B vaccination in renal transplant recipients. Am J Transplant 2: 965-969
39. Micozkadioglu H et al. (2007) Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients. Ren Fail 29: 285-288
40. Stark K et al. (1999) Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis 180: 2014-2017
41. Günther M et al. (2001) Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation 71: 477-479
42. Rytel MW et al. (1986) Pneumococcal vaccine immunization of patients with renal impairment. Proc Soc Exp Biol Med 182: 468-473
43. Robinson J (2004) Efficacy of pneumococcal immunization in patients with renal disease - what is the data? Am J Nephrol 24: 402-409
44. Blumberg EA et al. (2001) Immunogenicity of pneumococcal vaccine in heart transplant recipients. Clin Infect Dis 32: 307-310
45. Kumar D et al. (2003) Randomized, double-blind controlled trial of pneumococcal vaccine in renal transplant recipients. J Infect Dis 187: 1639-1645
46. Kumar D et al. (2007) Immunogenicity of pneumococcal vaccine in renal transplant recipients - three year follow-up of a randomized trial. Am J Transplant 7: 633-638
47. Scharpé J et al. (2008) Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 8: 332-337
48. Sanchez-Fructuoso AI et al. (2000) Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine. Transplantation 69: 436-439
49. Blumberg EA et al. (1996) The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 22: 295-302
50. Kretsinger K et al. (2006) Preventing tetanus, diphtheria and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 55: 1-37
51. Huzly D et al. (1997) Routine immunizations in adult renal transplant recipients. Transplantation 63: 839-845
52. Pedrazzi C et al. (1999) Duration of immunity to diphtheria and tetanus in young kidney transplant patients. Pediatr Transplant 3: 109-114
53. Broyer M et al. (1997) Varicella and zoster in children after kidney transplantation: long-term results of vaccination. Pediatrics 99: 35-39
54. Geel AL et al. (2006) Varicella zoster serostatus before and after kidney transplantation, and vaccination of adult kidney transplant candidates. Transplant Proc 38: 3418-3419
55. Furth SL et al. (2003) Varicella vaccination in children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 18: 33-38
56. Buttery JP and Moxon ER (2000) Varicella vaccine in renal failure. Lancet 355: 1930
57. Zamora I et al. (1994) Attenuated varicella virus vaccine in children with renal transplants. Pediatr Nephrol 8: 190-192
58. Chaves Tdo S et al. (2005) Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients. Pediatr Transplant 9: 192-196
59. Kimberlin DW and Whitley RJ (2007) Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med 356: 1338-1343
60. Avery RK and Michaels M (2008) Update on immunizations in solid organ transplant recipients: what clinicians need to know. Am J Transplant 8: 9-14
61. [No authors listed] (1996) Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 45: 1-30
62. Centers for Disease Control and Prevention (online 18 June 2007) The Yellow Book. The Immunocompromised Traveler [http://wwwn.cdc.gov/travel/ yellowBookCh9-Immunocompromised.aspx] (accessed 3 September 2008)
63. Cetron MS et al. (2002) Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep 51: 1-11